Vagus Nerve Stimulation for the Treatment of Epilepsy

Vagus nerve stimulation (VNS) was the first neuromodulation device approved for treatment of epilepsy. In more than 20 years of study, VNS has consistently demonstrated efficacy in treating epilepsy. After 2 years, approximately 50% of patients experience at least 50% reduced seizure frequency. Adve...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neurosurgery clinics of North America Ročník 30; číslo 2; s. 219
Hlavní autoři: González, Hernán F J, Yengo-Kahn, Aaron, Englot, Dario J
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States 01.04.2019
Témata:
ISSN:1558-1349, 1558-1349
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Vagus nerve stimulation (VNS) was the first neuromodulation device approved for treatment of epilepsy. In more than 20 years of study, VNS has consistently demonstrated efficacy in treating epilepsy. After 2 years, approximately 50% of patients experience at least 50% reduced seizure frequency. Adverse events with VNS treatment are rare and include surgical adverse events (including infection, vocal cord paresis, and so forth) and stimulation side effects (hoarseness, voice change, and cough). Future developments in VNS, including closed-loop and noninvasive stimulation, may reduce side effects or increase efficacy of VNS.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:1558-1349
1558-1349
DOI:10.1016/j.nec.2018.12.005